These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 20095649

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF, Kuppusamy R, Sarracino DA, Prakash A, Athanas M, Krastins B, Rezai T, Sutton JN, Peterman S, Nicolaides K.
    J Proteome Res; 2011 Jan 07; 10(1):133-42. PubMed ID: 20499897
    [Abstract] [Full Text] [Related]

  • 4. Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry.
    Raymackers J, Daniels A, De Brabandere V, Missiaen C, Dauwe M, Verhaert P, Vanmechelen E, Meheus L.
    Electrophoresis; 2000 Jun 07; 21(11):2266-83. PubMed ID: 10892737
    [Abstract] [Full Text] [Related]

  • 5. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T, Ackermann BL, Inoue K, Berna MJ, Garner CO, Gelfanova V, Dean RA, Siemers ER, Holtzman DM, Farlow MR, Blair IA.
    Rapid Commun Mass Spectrom; 2006 Jun 07; 20(24):3723-35. PubMed ID: 17117458
    [Abstract] [Full Text] [Related]

  • 6. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T, Hanrieder J, Bergquist J.
    J Mass Spectrom; 2008 May 07; 43(5):559-71. PubMed ID: 18416436
    [Abstract] [Full Text] [Related]

  • 7. Identification of potential CSF biomarkers in ALS.
    Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L.
    Neurology; 2006 Apr 25; 66(8):1218-22. PubMed ID: 16481598
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phosphoproteomics by mass spectrometry and classical protein chemistry approaches.
    Salih E.
    Mass Spectrom Rev; 2005 Apr 25; 24(6):828-46. PubMed ID: 15538747
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis.
    Shores KS, Knapp DR.
    J Proteome Res; 2007 Sep 25; 6(9):3739-51. PubMed ID: 17696521
    [Abstract] [Full Text] [Related]

  • 20. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J, Pernemalm M, Tan CS, Lindberg M, Kanter L, Pawitan Y, Lewensohn R, Stenke L, Lehtiö J.
    J Proteome Res; 2008 Jun 25; 7(6):2332-41. PubMed ID: 18452325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.